Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bruning

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Nature Communications|November 24, 2025
A ternary switch model governing ERα ligand binding domain conformationDaniel P McDougal, Jordan L Pederick, Scott J Novick, et al.
Nuclear Receptor Research|March 26, 2019
Structural and Dynamic Elucidation of a Non-acid PPAR<i>γ</i> Partial Agonist: SR1988Rebecca L Frkic, Benjamin S Chua, Youseung Shin, et al.
Inorganic Chemistry|December 15, 2021
To Be, or Not to Be, an Inhibitor: A Comparison of Azole Interactions with and Oxidation by a Cytochrome P450 EnzymeMatthew N Podgorski, Tom Coleman, Peter D Giang, et al.
The Biochemical Journal|June 22, 2022
Characterization of functionally deficient SIM2 variants found in patients with neurological phenotypesEmily L Button, Joseph J Rossi, Daniel P McDougal, et al.
Journal of Inorganic Biochemistry|April 28, 2023
Cytochrome P450-catalyzed oxidation of halogen-containing substratesTom Coleman, Matthew N Podgorski, Maya L Doyle, et al.
Biophysical Reports|March 23, 2023
Proteoliposomes reconstituted with human aquaporin-1 reveal novel single-ion-channel propertiesSam W Henderson, Yoshitaka Nakayama, Murray L Whitelaw, et al.
ACS Chemical Biology|November 19, 2015
SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial AgonismLaura M van Marrewijk, Steven W Polyak, Marcel Hijnen, et al.
Cellular and Molecular Life Sciences : CMLS|April 9, 2021
TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodellingJianling Xie, Stuart P De Poi, Sean J Humphrey, et al.
Journal of Medicinal Chemistry|May 10, 2017
Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted AntidiabeticsRebecca L Frkic, Yuanjun He, Beatriz B Rodriguez, et al.
Chemistry, an Asian Journal|October 21, 2022
Exploring the Factors which Result in Cytochrome P450 Catalyzed Desaturation Versus HydroxylationTom Coleman, Daniel Z Doherty, Ting Zhang, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Nature Communications|November 24, 2025
A ternary switch model governing ERα ligand binding domain conformationDaniel P McDougal, Jordan L Pederick, Scott J Novick, et al.
Nuclear Receptor Research|March 26, 2019
Structural and Dynamic Elucidation of a Non-acid PPAR<i>γ</i> Partial Agonist: SR1988Rebecca L Frkic, Benjamin S Chua, Youseung Shin, et al.
Inorganic Chemistry|December 15, 2021
To Be, or Not to Be, an Inhibitor: A Comparison of Azole Interactions with and Oxidation by a Cytochrome P450 EnzymeMatthew N Podgorski, Tom Coleman, Peter D Giang, et al.
The Biochemical Journal|June 22, 2022
Characterization of functionally deficient SIM2 variants found in patients with neurological phenotypesEmily L Button, Joseph J Rossi, Daniel P McDougal, et al.
Journal of Inorganic Biochemistry|April 28, 2023
Cytochrome P450-catalyzed oxidation of halogen-containing substratesTom Coleman, Matthew N Podgorski, Maya L Doyle, et al.
Biophysical Reports|March 23, 2023
Proteoliposomes reconstituted with human aquaporin-1 reveal novel single-ion-channel propertiesSam W Henderson, Yoshitaka Nakayama, Murray L Whitelaw, et al.
ACS Chemical Biology|November 19, 2015
SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial AgonismLaura M van Marrewijk, Steven W Polyak, Marcel Hijnen, et al.
Cellular and Molecular Life Sciences : CMLS|April 9, 2021
TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodellingJianling Xie, Stuart P De Poi, Sean J Humphrey, et al.
Journal of Medicinal Chemistry|May 10, 2017
Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted AntidiabeticsRebecca L Frkic, Yuanjun He, Beatriz B Rodriguez, et al.
Chemistry, an Asian Journal|October 21, 2022
Exploring the Factors which Result in Cytochrome P450 Catalyzed Desaturation Versus HydroxylationTom Coleman, Daniel Z Doherty, Ting Zhang, et al.
Pageof 13